Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

GSK plc sell BiotechBee

Start price
€15.10
23.09.22 / 70%
Target price
€10.00
31.12.24
Performance (%)
11.64%
End price
€16.86
01.11.22
Summary
This prediction ended on 01.11.22 with a price of €16.86. The SELL prediction by BiotechBee finished with a performance of 11.64%. BiotechBee has 70% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
GSK plc 2.946% 2.946% 23.688%
iShares Core DAX® 1.883% 5.122% 21.667%
iShares Nasdaq 100 0.125% 2.574% 45.951%
iShares Nikkei 225® -0.201% 4.341% 28.806%
iShares S&P 500 0.728% 4.141% 34.630%

According to BiotechBee what are the pros and cons of GSK plc for the foreseeable future?

Pros
Could be worthwhile Investment >10% per year
Cons

Comments by BiotechBee for this prediction

In the thread GlaxoSmithKline plc diskutieren
Prediction Sell
Perf. (%) 11.64%
Target price 10.000
Change
Ends at 31.12.24

Sell mit Kursziel 10,0

In the thread Trading GlaxoSmithKline plc
Prediction Sell
Perf. (%) 11.64%
Target price 10.000
Change
Ends at 31.12.24

Sell beendet

Stopped prediction by BiotechBee for GSK plc

buy
GSK plc

Start price
Target price
Perf. (%)
€16.86
01.11.22
€25.00
31.12.24
-0.27%
05.05.23

Could be worthwhile Investment >10% per year